Entera Bio Stock Could More Than Double From Here, Says Analyst

In the biotech space, big announcements often precede big share price movements; both were on tap for Entera Bio (ENTX) on Wednesday.
Entera shares took off after the company provided an update from the placebo-controlled, double blind Phase 2 trial of…

Click here to view the original article.